PharmedOut In the News - 2020
November 15: Dr. Fugh-Berman was quoted by Mad In America on the marketing of expensive tardive dyskinesia drugs.
Photos from PharmaBait, PharmedOut's collection of promotional items distributed by pharmaceutical companies, made an appearance in multiple articles in Mad In America.
Dr. Fugh-Berman was recently quoted by Reuters on Hemophilia drug manufacturers: “Industry’s relationship with individual patients or health care providers is always about selling specific targeted products."
September 15: The first PharmedOut webinar on Institutional Corruption and Clinical Practice Guidelines, with Joel Lexchin MD and Lisa Cosgrove PhD was featured on Mad In America's website.
August 23: Dr. Fugh-Berman's letter to the editor was published in the Washington Post, defending randomized controlled trials given the emergency-use authorization of convalescent plasma by the Food and Drug Administration to treat COVID-19.
PharmedOut was featured in the International Society of Drug Bulletins (ISDB) latest newsletter as one of their newest associate members. Founded in 1986, the ISDB is a world-wide network of pharma-free bulletins and journals on drugs and therapeutics.
PharmedOut's intern, Daisy Daeschler, was recently featured in the National Women's Health Network newsletter's Rx for Change column with her article Is your Doctor Treating Your Social Needs?
July 25: PharmaBait, our recently-released collection of drug rep promotional items, is already being featured on multiple platforms online! Most recently, an image from PharmaBait was used in an article in Mad In America.
July 21: Dr. Fugh-Berman was quoted in a Pain News Network article on what the US Pain Foundation should have done with the $210,000 they received from Insys Therapeutics.
Dr. Sharon Batt and Dr. Fugh-Berman’s article, Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective was mentioned in several blogs this July, including BigThink and Mad in America.
We are pleased to announce that PharmedOut was recently granted associated membership to the International Society of Drug Bulletins (ISDB). Founded in 1986, the ISDB is a world-wide network of pharma-free bulletins and journals on drugs and therapeutics.
May 7: Jinhyun Jung, PharmD, who recently graduated from the University of North Carolina Eshelman School of Pharmacy and Dr. Fugh-Berman's study Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED) was highlighted in Mad in America.
May 7: Former project manager Alessandra Hirsch, now an OB/GYN at the University of Chicago wrote an op-ed for the Pittsburgh Tribune-Review detailing the challenges healthcare workers face in this pandemic and why their student loans should be forgiven.
April 16: Dr. Fugh-Berman was quoted in a Consumer Reports article about off-label prescribing and coronavirus. "Companies can't advertise their drugs for off-label use, but doctors often learn about them, legally, through medical literature provided by drug company sales reps or from continuing medical education" says Fugh-Berman.
February 27: Dr. Fugh-Berman was quoted in a Stat News article about an upcoming New York Academy of Sciences conference on conflicts of interest that is funded by Johnson and Johnson. "This is a conflict of interest conference with a conflict of interest" says Fugh-Berman.